Who owns ASLAN PHARMACEUTICALS LTD?

Tip: Access positions for across all investors

Analyze quarterly positions in Aslan Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Aslan Pharmaceuticals stock

Who bought or sold ASLAN PHARMACEUTICALS LTD this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
BVF 1.0M $548k 0% Dec 2023
 View chart
UBS Group 625k $326k 100% Dec 2023
 View chart
Citadel Advisors 489k $255k 174% Dec 2023
 View chart
Shay Capital 400k $209k 100% Dec 2023
 View chart
Landscape Capital Management 83k $44k 100% Dec 2023
 View chart
Millennium Management 80k $42k 0% Dec 2023
 View chart
Waterfront Wealth 41k $21k -17% Dec 2023
 View chart
Ikarian Capital 35k $6.5k 0% Dec 2023
 View chart
Schonfeld Strategic Advisors 28k $15k -70% Dec 2023
 View chart
Jane Street 23k $12k 100% Dec 2023
 View chart
Onyx Bridge Wealth Group 23k $12k 100% Dec 2023
 View chart
Capital Analysts 2.0k $999.925600 0% Dec 2023
 View chart
Rhumbline Advisers 1.3k $674.044600 0% Dec 2023
 View chart
Cutler 1.2k $0 20% Mar 2024
 View chart
Simplex Trading 1.2k $0 15% Dec 2023
 View chart

Who sold out of Aslan Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
Tang Capital Management Sep 2023 1.9M $3.6M
Citigroup Sep 2023 58k $107k